A poliovirus-susceptible transgenic mouse model as a possible replacement for the monkey neurovirulence test of oral poliovirus vaccine

Biologicals

Volumn 24, Issue 2, 1996, Pages 77-86

  Dragunsky, E ^a   Taffs, R ^a   Chernokhvostova, Y ^a   Nomura, T ^b   Hioki, K ^b   Gardner, D ^a   Norwood, L ^a   Levenbook, I ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; INTRACEREBRAL DRUG ADMINISTRATION; MONKEY; MOUSE; NONHUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS; POLIOVIRUS;

EID: 0030175035     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.1996.0010     Document Type: Article

References (18)

1. 1. Ren R, Costantini F, Gorgacz EJ, Lee JJ, Racaniello VR. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell 1990; 63: 353-362.
2. 2. Koike S, Taya C, Kurata T, Abe S, Ise I, Yonekawa H, Nomoto A. Transgenic mice susceptible to poliovirus. Proc Natl Acad Sci USA 1991; 88: 951-955.
3. 3. Horie H, Koike S, Kurata T, Sato Yoshida Y, Ise I, Ota Y, Abe S, Hioki K, Kato H, Taya C, Nomura T, Hashizume S, Yonekawa H, Nomoto A. Transgenic mice carrying the human poliovirus receptor: new animal model for study of poliovirus neurovirulence. J Virol 1994; 68: 681-688.
4. 4. Koike S, Taya C, Aoki J, Matsuda Y, Ise I, Takeda H, Matsuzaki T, Amanuma H, Yonekawa H, Nomoto A. Characterization of three different transgenic mouse lines that carry human poliovirus reeptor gene - influence of the transgene expression on pathogenesis. Arch Virol 1994; 139: 351-363.
5. 5. Abe S, Ota Y, Koike S, Kurata T, Horie H, Nomura T, Hashizume S, Nomoto A. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice. Virology 1995; 208: 1075-1083.
6. 6. Chumakov KM, Powers LB, Noonan KE, Roninson IB, Levenbook IS. Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proc Natl Acad Sci USA 1991; 88: 199-203.
7. 7. Chumakov K, Norwood L, Parker M, Dragunsky E, Taffs R, Ran Y, Ridge J, Levenbook I. Assessment of the viral RNA sequence heterogeneity for control of OPV neurovirulence. Dev Biol Stand 1992; 78: 77-86.
8. 8. Rezapkin GV, Chumakov KM, Lu Z, Ran Y, Dragunsky E, Levenbook I. Microevolution of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine. Virology 1994; 202: 370-378.
9. 9. Taffs R, Chumakov K, Rezapkin G, Lu Z, Douthitt M, Dragunsky E, Levenbook I. Mutant selection in Sabin 2 strain grown in different cell culture conditions and genetic stability of oral poliovirus vaccine. Virology 1995; 209: 366-373.
10. 10. Dragunsky E, Gardner D, Taffs R, Levenbook I. Transgenic PVR Tg-1 mice for testing of poliovirus type 3 neurovirulence: comparison with monkey test. Biologicals 1993; 21: 233-237.
11. 11. US Code of Federal Regulations. Title 21, Part 630. Subpart B - Poliovirus Vaccine Live Oral Trivalent. Washington, DC: US Government Printing Office, 1994.
12. 12. Maintenance and distribution of transgenic mice susceptible to human viruses: Memorandum from a WHO meeting. WHO Bull OMS 1993; 71: 497-502.
13. 13. Guide for the Care and Use of Laboratory Animals. US, DHHS, PHS, NIH, NIH Publication No. 85-23, 1985.
14. 14. Lehman A, Sall J. JMP® User's Guide, SAS Institute Inc., Cary, NC, 1994.
15. 15. Goodman L. Analyzing Qualitative/Categorical Data. Log-linear Models and Latent Structure Analysis. Abt Associates Inc. Cambridge, MA, 1978.
16. 16. Kalbfleisch J, Prentice R. The Statistical Analysis of Failure Time Data. John Wiley and Sons, New York, 1980.
17. 17. Bowling M. Histopathology Laboratory Procedures. Washington, DC, US Government Printing Office, 1967.
18. 18. Requirements for poliomyelitis vaccine (oral). WHO Tech Rep Ser 1990; 800: 46-49.